Search Results1-20 of  91

  • 1 / 5
  • OGATA HIROYASU ID: 9000398804955

    Articles in CiNii:1

    • A SHORT NOTE ON THE URINARY EXCRESION PROCESS (1987)
  • OGATA HIROYASU ID: 9000398805005

    Articles in CiNii:1

    • ON THE CV OF THE RATE CONSTANT (1985)
  • OGATA HIROYASU ID: 9000398805049

    Articles in CiNii:1

    • KINETICS OF URINARY EXCRETION RATE FROM THE VIEWPOINT OF THE ALMOST-ONE PARAMETER HYPOTHESIS (1984)
  • OGATA HIROYASU ID: 9000398805078

    Articles in CiNii:1

    • INDIVIDUALITY OF METABOLISM FROM THE VIEWPOINT OF THE ALMOST-ONE PARAMETER HYPOTHESIS (1984)
  • OGATA HIROYASU ID: 9000398805081

    Articles in CiNii:1

    • FURTHER ANALYSIS OF THE METABOLIC DATA FROM THE VIEWPOINT OF THE ALMOST-ONE PARAMETER HYPOTHESIS (1984)
  • OGATA HIROYASU ID: 9000001970098

    Clinical Pharmacy Course, Graduate School of Pharmaceutical Sciences, Meiji Pharmaceutical University (2007 from CiNii)

    Articles in CiNii:1

    • Clinical Characteristics Influencing the Effectiveness of Metformin on Japanese Type 2 Diabetes Receiving Sulfonylureas (2007)
  • OGATA HIROYASU ID: 9000002861753

    Articles in CiNii:107

    • Preparation and Properties of Liposomes Stabilized with Pluronic F-68 (1994)
    • Development of Tacrolimus Nomogram for Estimating the Optimal Oral Dose in Pediatric Kidney Transplant Patients - Preliminary Sturdy - (2001)
    • PPK解析法における薬物相互作用の検出力に関する検討 (2001)
  • OGATA HIROYASU ID: 9000014203571

    Meiji Pharmaceutical University, Department of Biopharmaceutics (2008 from CiNii)

    Articles in CiNii:1

    • A new concept and a theoretical consideration of the mechanism-based pharmacokinetics/pharmacodynamics (PK/PD) modeling for antimicrobial agents (2008)
  • OGATA HIROYASU ID: 9000253211354

    Articles in CiNii:1

    • The bioavailabilities of aspirin from an aspirin aluminum and an aspirin tablets and the effects of food and aluminum hydroxide gel. (1981)
  • OGATA HIROYASU ID: 9000253211794

    Articles in CiNii:1

    • Effect of food on the bioavailability of griseofulvin from microsize and PEG ultramicrosize (GRIS-PEGR) plain tablets. (1982)
  • OGATA HIROYASU ID: 9000253211831

    Articles in CiNii:1

    • The bioavailability of flufenamic acid from aluminum flufenamate tablet and flufenamic acid capsule, and the influence of food and aluminum hydroxide gel. (1982)
  • OGATA HIROYASU ID: 9000253212566

    Articles in CiNii:1

    • Bioavailability of griseofulvin from plain tablets in Goettingen minipigs and the correlation with bioavailability in humans. (1984)
  • OGATA HIROYASU ID: 9000253212639

    Articles in CiNii:1

    • Effect of food on bioavailability of nalidixic acid from uncoated tablets having different dissolution rates. (1984)
  • OGATA HIROYASU ID: 9000253213023

    Articles in CiNii:1

    • Bioavailability of griseofulvin plain tablets in stomach-emptying controlled rabbits and the correlation with bioavailability in humans. (1984)
  • OGATA HIROYASU ID: 9000253213074

    Articles in CiNii:1

    • Development and evaluation of a new peroral test agent GA-test for assessment of gastric acidity. (1984)
  • OGATA HIROYASU ID: 9000254217673

    Articles in CiNii:1

    • Stability of sulpyrine. IV. Reaction with glucose in aqueous solution. (1979)
  • OGATA HIROYASU ID: 9000254217807

    Articles in CiNii:1

    • Studies on dissolution tests of solid dosage forms. IV. Relation of absorption sites of sulfonamides administered orally in solid dosage form to their solubilities and dissolution rates. (1979)
  • OGATA HIROYASU ID: 9000254220271

    Articles in CiNii:1

    • Biopharmaceutical studies on the clinical inequivalence of two carbutamide tablets. (1982)
  • OGATA HIROYASU ID: 9000254225623

    Articles in CiNii:1

    • Bioavailability of pyridoxal phosphate from enteric-coated tablets. I. Apparent critical dissolution pH and bioavailability of commercial products in humans. (1985)
  • OGATA HIROYASU ID: 9000254225688

    Articles in CiNii:1

    • Bioavailability of pyridoxal phosphate from enteric-coated tablets. III. Correlations between bioavailability in humans and beagle dogs and between bioavailability in humans and in vitro dissolution rates. (1985)
  • 1 / 5
Page Top